Toggle navigation

Australian and New Zealand Healthcare Professionals only

For Patients only

Home

Log-in

*Password

1

*Required field

This information is for patients prescribed PLEGRIDY^® (peginterferon beta-1a) only. This information does not replace the advice of your healthcare professional. Please consult your doctor if you have any questions or concerns about your medication or MS.

Before prescribing TYSABRI (natalizumab) a Prescription Medicine, funded under Special Authority Criteria for the treatment of patients with relapsing remitting multiple sclerosis (MS) review the full data sheet available at medsafe.govt.nz for information on dosage, contra-indications, precautions, interactions and adverse events. Biogen NZ Biopharma Limited Auckland.

PRIVACY STATEMENT: Biogen complies with the Australian Privacy Principles. Biogen collects and uses your information to register you and provide appropriate services for this event. Biogen may share the information with Biogen’s group companies (located outside of Australia) and with selected third party service providers (who may also be located outside of Australia) and as required by law. You may request access to and/or amend your personal information by contacting our Privacy Officer on privacy.officer@biogen.com. For our full Privacy Policy and contact details visit www.biogen.com.au

Biogen Australia Pty Ltd. ABN 30 095 760 115. Biogen Australia, Macquarie Park, NSW. Biogen NZ Biopharma Limited, Auckland, New Zealand. ^®Biogen, TECFIDERA^®, TYSABRI^® ©2021 Biogen Inc. All rights reserved. Date of preparation: December 2020. Biogen-87987 and PLEGRIDY^® are registered trademarks of Biogen MA Inc. Date of preparation: Biogen-172490, August 2022. ©2021 Biogen Inc. All rights reserved. TAPS No: PP3772. Date of preparation: May 2021. Biogen-68237 ^®Biogen, TECFIDERA^® are registered trademarks of Biogen MA Inc. ^®Biogen, and TYSABRI^® are registered trademarks of Biogen MA Inc. ©2019 Biogen Inc. All rights reserved. TAPS No: PP3772. Date of preparation: April 2019. Biogen-10681. ©2019 Biogen Inc. All rights reserved. TAPS No: PP3772. Date of preparation: April 2019. Biogen-03909. ©2019 Biogen Inc. All rights reserved. Biogen-24115 TAPS No: PP4749. BIOG0674/EMBC Date of preparation: October 2019. ^®Biogen, PLEGRIDY^® are registered trademarks of Biogen MA Inc. ©2019 Biogen Inc. All rights reserved. Date of preparation: April 2019. Biogen-05139 ©2019 Biogen Inc. All rights reserved. Date of preparation: May 2023. Biogen-209927 ^®Biogen, VUMERITY^TM and TECFIDERA^® are registered trademarks of Biogen MA Inc. ©2022 Biogen Inc. All rights reserved. Date of preparation: May 2022. Biogen-170534.

Privacy Policy
Cookies

*Required fields

*

*

*

*

×

Thank you for enrolling

x

Close

Your information has been updated

x

Close

Are you sure you want to opt out of email reminders?

x

Yes, I no longer wish to receive reminders No, keep sending me reminders

Please note that unsubscribing from medication reminders does not mean that you are unsubscribed from other emails that you are currently signed up to receive from Biogen.

You have successfully opted out of medication reminders

x

Close